[177Lu]Lu-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study

The Lancet Oncology 2026

View at publisher
Authors: Bastiaan M. Privé, Walter Noordzij, Stijn Muselaers, Igle J. de Jong, Inge M. van Oort, Marcel J. R. Janssen, Maartje C. van Rijk, Willemijn A. van Gemert, Bart Timmermans, Minke Groot, Niven Mehra, W.R. Gerritsen
+9 more Marianne A. Jonker, Emmanouil Alevroudis, Suzanne van der Gaag, Josephina C C Koppes, J P Michiel Sedelaar, André N. Vis, Alexis Vrachimis, Daniela E Oprea-Lager, James Nagarajah
DOI: 10.1016/s1470-2045(25)00762-4
Cited by: 14
References: 30

Fields of Study & Subjects

Prostate Cancer Treatment and Research Radiopharmaceutical Chemistry and Applications Prostate Cancer Diagnosis and Treatment

Publication details

Journal / source
The Lancet Oncology
Publisher
Elsevier BV
Volume
27
Issue
4
Pages
461–469
Publication date
31 March 2026
Language
EN